Condition: Cutaneous Squamous Cell Carcinoma of the Head and Neck · Clinically Node-Negative (cN0) · High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck · Sponsor: University of California, Davis
This is a phase 2 pragmatic study at a single site that evaluates the clinical benefit of SLNB in patients with high-risk cSCC and cN0. The primary goal is to evaluate the efficacy of SLNB based on the DFS rate at 2 years post-definitive therapy.
This description comes directly from the study's public registry record.
Selina Laqui · 916-734-0565 · sblaqui@ucdavis.edu
Always discuss trial participation with your own doctor first.
| University of California, Davis | Sacramento, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06990737